3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
5
Ovarian Neoplasms
2
Colorectal Neoplasms
2
Tuberous Sclerosis
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pediatric Solid Tumor
1
Pancreatic Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Lymphangioleiomyomatosis
1
Histiocytosis, Non-Langerhans-Cell
1
Histiocytosis, Langerhans-Cell
1
HER2-positive Breast Cancer
1
Early Detection of Cancer
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Castleman Disease
1
Breast Screening
1
Breast Neoplasms, Male
1
Brain Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
2
pembrolizumab
1
dehydroftorafur
1
atezolizumab
1
RAD51C protein, human
1
Oxaliplatin
1
Naproxen
1
Leucovorin
1
Health Promotion
1
Genetic Testing
1
G-T mismatch-binding protein
1
Fluorouracil
1
Endoscopy
1
Educational Status
1
Diffusion Tensor Imaging
1
Diet Therapy
1
Data Collection
1
Colonoscopy
1
Capsule Endoscopy
1
Biopsy
1
Aspirin
1
Artificial Intelligence
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colorectal Neoplasms, Hereditary Nonpolyposis
×
Genetic Testing
×
90 days
×
Clear all
NCT07498829
2026-03-27
PROTECT-C
Queen Mary University of London
Phase NA
Recruiting
6,000 enrolled